Free tool
FAERS Monitor: Ozurdex
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 022315 or its brand name (Ozurdex, Dexamethasone). Reports on generic versions are filed under their own applications.
Reports
297,995
Serious
251,860
85% of reports
Hospitalization
114,352
Death reported
48,238
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use22,933
- fatigue17,499
- diarrhoea17,302
- plasma cell myeloma14,401
- nausea14,181
- pneumonia13,820
- death13,532
- drug ineffective13,296
- neutropenia11,780
- pyrexia11,109
- thrombocytopenia10,774
- dyspnoea10,386
- febrile neutropenia9,200
- anaemia9,126
- vomiting8,891
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1,561 |
| 2005 | 2,135 |
| 2006 | 1,096 |
| 2007 | 875 |
| 2008 | 1,308 |
| 2009 | 1,923 |
| 2010 | 3,594 |
| 2011 | 5,449 |
| 2012 | 6,776 |
| 2013 | 6,788 |
| 2014 | 8,419 |
| 2015 | 17,458 |
| 2016 | 15,932 |
| 2017 | 17,974 |
| 2018 | 23,448 |
| 2019 | 23,468 |
| 2020 | 25,390 |
| 2021 | 29,153 |
| 2022 | 27,447 |
| 2023 | 24,384 |
| 2024 | 21,709 |
| 2025 | 18,734 |
| 2026 | 12,972 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,756,164 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| plasma cell myelomaSignal | 14,401 | 40.7 | 39.9 | 352,538 |
| febrile neutropeniaSignal | 9,200 | 11.2 | 11.0 | 73,866 |
| thrombocytopeniaSignal | 10,774 | 7.4 | 7.3 | 54,351 |
| neutropeniaSignal | 11,780 | 6.6 | 6.5 | 51,453 |
| anaemiaSignal | 9,126 | 3.5 | 3.4 | 15,630 |
| pneumoniaSignal | 13,820 | 3.1 | 3.1 | 19,144 |
| pyrexiaSignal | 11,109 | 2.3 | 2.3 | 8,103 |
| diarrhoea | 17,302 | 1.9 | 1.9 | 7,612 |
| off label use | 22,933 | 1.9 | 1.8 | 9,453 |
| fatigue | 17,499 | 1.6 | 1.6 | 3,995 |
| vomiting | 8,891 | 1.3 | 1.3 | 774 |
| dyspnoea | 10,386 | 1.3 | 1.3 | 727 |
| nausea | 14,181 | 1.3 | 1.2 | 828 |
| death | 13,532 | 1.1 | 1.1 | 152 |
| drug ineffective | 13,296 | 0.7 | 0.7 | 1,675 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.